Home Daily Stock Opinions and Ratings Salona Global Medical (SGMD-X)

Trending stocks today

MDA Ltd. Microsoft Corp Morguard Corporation CNHI Industrial Halliburton Co Cenovus Energy Chartwell Retirement Residences Granite REIT Bank of America Chevron Texaco Dycom Industries Tesla Inc Verizon Communications British American Tobacco RenaissanceRe Holdings United Therapeutics Corp. Keg Royalties Income Fund CGI Group (A) Yum China Holdings Inc Brookfield Infrastructure Partners

Salona Global Medical (SGMD-X)

NEW AI Investor Insights
47 watching

CVE:SGMD

0.22
0.01 (2.33%) 1d
Jan 12, 2024, 8:50 pm
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

According to the reviews, Salona Global Medical (SGMD-X) has achieved its desired revenue base and is starting to cross-sell products. The new management has a focus on profitability, and technology is expected to aid in this goal. Despite a significant decline in stock value, experts believe this company offers amazing value right now.

Consensus
Positive
Valuation
Undervalued
Similar
MediWound, MDWD
PAST TOP PICK

Salona Global Medical(SGMD-X)

13/09/2023
Salona Global Medical
(A Top Pick Jul 04/22, Down 79%)

Achieved desired revenue base and starting to cross-sell products. New management focus on profitability, and technology should help. Amazing value right now.

Healthcare
Bruce Campbell (2)
$0.180
Owned
UnlockRating
BUY

Salona Global Medical(SGMD-X)

19/01/2023
Salona Global Medical
Underlying business still working fantastically. Comes down to market size and market cap. Trades at around 1x sales, whereas peers are around 3x sales. As they continue to grow organically and by acquisition, revenue keeps going up. Announced NASDAQ listing, which will boost multiple. Acquisition in progress should boost revenue by 35-40%, share price should move up.
Healthcare
Bruce Campbell (2)
$0.470
Unknown
UnlockRating
TOP PICK

Salona Global Medical(SGMD-X)

21/11/2022
Salona Global Medical
It is in the recovery science market related to physiotherapy with machines to help patients recover from injury or surgery. It was formed one and a half years ago with 15 million in revenue growing to 50 million now, Could be 80 million by year end. Also it is profitable. The founder has successfully built out a company in a similar space and taken it from 150 million to 1.5 billion in six years then sold it to a private equity firm. Buy 2, Hold 0, Sell 0.
Healthcare
Bruce Campbell (2)
$0.590
Owned
UnlockRating
BUY

Salona Global Medical(SGMD-X)

21/10/2022
Salona Global Medical

Has owned stock in the company before. Company executing well and is well managed. Founder is experienced in business. Expecting revenue to grow. Margins growing fast.

Healthcare
Bruce Campbell (2)
$0.540
Owned
UnlockRating
BUY

Salona Global Medical(SGMD-X)

27/09/2022
Salona Global Medical
A headwind is that it's a small-cap which the market is not buying now. Management team has a great track record. From June 2021, they've grown the company from $10 million of annual run rate revenue to $90 million (after some acquisitions). More acquisitions and organic growth lie ahead. They're profitable. It's his largest position. He sees shares going much higher.
Healthcare
Bruce Campbell (2)
$0.620
Owned
UnlockRating
TOP PICK

Salona Global Medical(SGMD-X)

22/08/2022
Salona Global Medical
Has also been a past pick. When it went public just over a year ago it had $16 million in revenue which should become $70 million by year end with acquisitions and 30% organic growth. Will apply to NASDAQ when it gets to $100 revenue next year. The chairman was in the same business with DJ global which over 6 years gained 10 times. There is lots of runway to buy a business and increase cash flow. Therefore no short-term need for capital raises. Trades at 1X revenue. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Healthcare
Bruce Campbell (2)
$0.750
Owned
UnlockRating
TOP PICK

Salona Global Medical(SGMD-X)

04/07/2022
Salona Global Medical
Its IPO was just over a year ago. Its CEO built up another company and sold it for a ten-fold gain. He is doing the same thing through organic growth and acquisitions. It is trading at 1X revenue but is growing fast so should be 5 to 8X revenue. It is one of his bigger positions. In 2 to 5 years it should hit the radar screen of investors and will probably be sold when it reaches a certain size. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Healthcare
Bruce Campbell (2)
$0.800
Owned
UnlockRating
PAST TOP PICK

Salona Global Medical(SGMD-X)

01/06/2022
Salona Global Medical
(A Top Pick Jun 29/21, Down 32%) Revenues jumped 100%, earnings up 140%. CEO delivered. Pullback is surprising. Valuation is much better now.
Healthcare
Bruce Campbell (2)
$0.750
Owned
UnlockRating
TOP PICK

Salona Global Medical(SGMD-X)

22/04/2022
Salona Global Medical

Believes management team is excellent. Company growing organically with a mix of M&A. Trading at 1.2x sales (peers trade at 4-8x sales). Expecting share price to rise significantly.

Healthcare
Bruce Campbell (2)
$0.930
Unknown
UnlockRating
BUY

Salona Global Medical(SGMD-X)

23/02/2022
Salona Global Medical
Non-hospital surgical and rehab equipment. Will grow both organically and by acquisition. Acquisitions have been delayed. Hit estimated revenue number, and this should continue. Obtained financing. Pipeline of deals. Earnings will be lumpy. Likes management. If it weren't too small, he'd make it a Top Pick.
Healthcare
Bruce Campbell (2)
$0.570
Owned
UnlockRating
BUY

Salona Global Medical(SGMD-X)

02/09/2021
Salona Global Medical
Continue to execute. Waiting for them to integrate acquisitions. Tremendous respect for the Chairman, as he's very picky on acquisitions. Bodes well for long-term success. As they grow market cap and show up on investors' radar, stock should close valuation gap with peers.
Healthcare
Bruce Campbell (2)
N/A
Unknown
UnlockRating
TOP PICK

Salona Global Medical(SGMD-X)

29/06/2021
Salona Global Medical
No price target A new company. The CEO comes from an orthotics company that he grew from $100 million to $600 million over six years until he sold it. Non-surgical devices have IP protection. They make small acquisitions and are talking to 50 small companies before they close these deals. He expects $55 revenues, but bigger deals will push that to $75-80 million. Trades at 1.2x revenues vs. peers' 4.5x-18x. Will grow by acquisition and organically as they expand into Europe.
Healthcare
Bruce Campbell (2)
N/A
Owned
UnlockRating
Showing 1 to 12 of 12 entries
  • «
  • ‹
  • 1
  • ›
  • »

Salona Global Medical(SGMD-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Salona Global Medical is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Salona Global Medical(SGMD-X) Frequently Asked Questions

What is Salona Global Medical stock symbol?

Salona Global Medical is a Canadian stock, trading under the symbol SGMD-X on the TSX Venture Exchange (SGMD-CV). It is usually referred to as TSXV:SGMD or SGMD-X

Is Salona Global Medical a buy or a sell?

In the last year, 1 stock analyst published opinions about SGMD-X. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Salona Global Medical.

Is Salona Global Medical a good investment or a top pick?

Salona Global Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Salona Global Medical.

Why is Salona Global Medical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Salona Global Medical worth watching?

1 stock analyst on Stockchase covered Salona Global Medical In the last year. It is a trending stock that is worth watching.

What is Salona Global Medical stock price?

On 2024-01-12, Salona Global Medical (SGMD-X) stock closed at a price of $0.22.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

FTS-TFortis Inc.
Fortis Inc.
$52.38
0.55 (1.04%)
BIP.UN-TBrookfield Infrastructure Partners
Brookfield Infrastructure Partners
$36.26
1.05 (2.81%)
BNS-TBank of Nova Scotia
Bank of Nova Scotia
$64.14
-0.08 (-0.12%)
TD-TToronto Dominion
Toronto Dominion
$78.85
0.57 (0.72%)
YUMC-NYum China Holdings Inc
Yum China Holdings Inc
$37.22
0.34 (0.91%)
Advertising

Today's Top Picks

BIP.UN-TBrookfield Infrastructure Partners
Brookfield Infrastructure Partners
$36.26
1.05 (2.81%)
YUMC-NYum China Holdings Inc
Yum China Holdings Inc
$37.22
0.34 (0.91%)
GIB.A-TCGI Group (A)
CGI Group (A)
$143.11
-0.86 (-0.60%)
KEG.UN-TKeg Royalties Income Fund
Keg Royalties Income Fund
$14.46
-0.03 (-0.18%)
UTHR-QUnited Therapeutics Corp.
United Therapeutics Corp.
$237.16
1.85 (0.77%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

AP.UN-TAllied Properties REIT
Allied Properties REIT
$17.00
0.46 (2.63%)
TSLA-QTesla Inc
Tesla Inc
$149.90
-5.55 (-3.84%)
CTC.A-TCanadian Tire Corporation Ltd. (A)
Canadian Tire Corporation Ltd. (A)
$129.56
0.99 (0.76%)
CWL-TCaldwell Partners Int'l (A)
Caldwell Partners Int'l (A)
$0.80
0.02 (2.44%)
TSLA-QTesla Inc
Tesla Inc
$149.90
-5.55 (-3.84%)

Most Recent Experts

Blumas

Chris Blumas

at Raymond James Investment Counsel Ltd.

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Reid

Gordon Reid

GoodReid Investment Counsel

Stockchase

Stockchase Insights

5i Research

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.